Hunan Jingfeng Pharmaceutical Co.,Ltd. (SHE:000908)
China
· Delayed Price · Currency is CNY 5.49
+0.16 (3.00%)
Apr 24, 2025, 2:45 PM CST
SHE:000908 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
| Operating Revenue | 386.18 | 645.32 | 822.56 | 771.86 | 866.83 | 1,339 | Upgrade
|
| Other Revenue | 11.58 | 11.58 | 18.1 | 39.33 | 11.09 | 5.21 | Upgrade
|
| Revenue | 397.76 | 656.89 | 840.66 | 811.18 | 877.92 | 1,344 | Upgrade
|
| Revenue Growth (YoY) | -49.18% | -21.86% | 3.63% | -7.60% | -34.68% | -48.02% | Upgrade
|
| Cost of Revenue | 180.67 | 197.92 | 205.82 | 323.64 | 330.55 | 538.42 | Upgrade
|
| Gross Profit | 217.09 | 458.97 | 634.83 | 487.55 | 547.37 | 805.61 | Upgrade
|
| Selling, General & Admin | 300.74 | 502.89 | 591.81 | 711.34 | 832.57 | 1,178 | Upgrade
|
| Research & Development | 47 | 52.51 | 35.64 | 38.63 | 252.88 | 191.3 | Upgrade
|
| Other Operating Expenses | 16.47 | 10.77 | 11.98 | 27.36 | 16.37 | 19.43 | Upgrade
|
| Operating Expenses | 355.89 | 563.35 | 654.27 | 797.37 | 1,246 | 1,399 | Upgrade
|
| Operating Income | -138.8 | -104.38 | -19.44 | -309.83 | -698.83 | -593.44 | Upgrade
|
| Interest Expense | -38.88 | -41.89 | -52.23 | -85.85 | -105.92 | -105.02 | Upgrade
|
| Interest & Investment Income | 4.27 | 5.3 | 1.12 | 249.89 | 224.55 | 73.12 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.04 | 0.04 | 0.15 | -0.05 | 0.65 | 0.48 | Upgrade
|
| Other Non Operating Income (Expenses) | 4.72 | 0.51 | 1.85 | -19.08 | -7.78 | -2.83 | Upgrade
|
| EBT Excluding Unusual Items | -168.65 | -140.42 | -68.54 | -164.92 | -587.32 | -627.7 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | -360.83 | -304.69 | Upgrade
|
| Gain (Loss) on Sale of Investments | 25.12 | 24.81 | 13.82 | -3.79 | -180.93 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 8.07 | 7.56 | 9.8 | 55.89 | -0.18 | 1.26 | Upgrade
|
| Asset Writedown | -84.85 | -83.76 | -39.56 | -42.79 | -19.24 | -0.47 | Upgrade
|
| Legal Settlements | -6.12 | -6.12 | -15.33 | -13.72 | - | - | Upgrade
|
| Other Unusual Items | -47.23 | 24.27 | 14.17 | 13.89 | -3.41 | 11.82 | Upgrade
|
| Pretax Income | -273.66 | -173.67 | -85.63 | -155.44 | -1,152 | -919.77 | Upgrade
|
| Income Tax Expense | 25.7 | 32.84 | 9.62 | 46.2 | 3.39 | 1.78 | Upgrade
|
| Earnings From Continuing Operations | -299.36 | -206.5 | -95.25 | -201.64 | -1,155 | -921.55 | Upgrade
|
| Minority Interest in Earnings | 13.35 | -8.64 | -27.31 | 37.98 | 86.79 | 38.75 | Upgrade
|
| Net Income | -286 | -215.14 | -122.56 | -163.66 | -1,069 | -882.81 | Upgrade
|
| Net Income to Common | -286 | -215.14 | -122.56 | -163.66 | -1,069 | -882.81 | Upgrade
|
| Shares Outstanding (Basic) | 879 | 880 | 880 | 880 | 883 | 883 | Upgrade
|
| Shares Outstanding (Diluted) | 879 | 880 | 880 | 880 | 883 | 883 | Upgrade
|
| Shares Change (YoY) | -0.11% | 0.01% | -0.01% | -0.36% | 0.03% | 0.33% | Upgrade
|
| EPS (Basic) | -0.33 | -0.24 | -0.14 | -0.19 | -1.21 | -1.00 | Upgrade
|
| EPS (Diluted) | -0.33 | -0.24 | -0.14 | -0.19 | -1.21 | -1.00 | Upgrade
|
| Free Cash Flow | 14.26 | 24.64 | 109.75 | 85.72 | -367.72 | -77.47 | Upgrade
|
| Free Cash Flow Per Share | 0.02 | 0.03 | 0.13 | 0.10 | -0.42 | -0.09 | Upgrade
|
| Gross Margin | 54.58% | 69.87% | 75.52% | 60.10% | 62.35% | 59.94% | Upgrade
|
| Operating Margin | -34.89% | -15.89% | -2.31% | -38.19% | -79.60% | -44.15% | Upgrade
|
| Profit Margin | -71.90% | -32.75% | -14.58% | -20.18% | -121.71% | -65.68% | Upgrade
|
| Free Cash Flow Margin | 3.59% | 3.75% | 13.05% | 10.57% | -41.89% | -5.76% | Upgrade
|
| EBITDA | -110.12 | -65.85 | 32.24 | -212.35 | -617.37 | -517 | Upgrade
|
| EBITDA Margin | -27.69% | -10.02% | 3.83% | -26.18% | -70.32% | -38.47% | Upgrade
|
| D&A For EBITDA | 28.68 | 38.53 | 51.68 | 97.47 | 81.45 | 76.44 | Upgrade
|
| EBIT | -138.8 | -104.38 | -19.44 | -309.83 | -698.83 | -593.44 | Upgrade
|
| EBIT Margin | -34.89% | -15.89% | -2.31% | -38.19% | -79.60% | -44.15% | Upgrade
|
| Revenue as Reported | 397.76 | 656.89 | 840.66 | 811.18 | 877.92 | 1,344 | Upgrade
|
| Advertising Expenses | - | 20.6 | 49.36 | 73.33 | 39.49 | 80.59 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.